BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 38229877)

  • 1. Post-acute COVID-19 neuropsychiatric symptoms are not associated with ongoing nervous system injury.
    Taquet M; Skorniewska Z; Zetterberg H; Geddes JR; Mummery CJ; Chalmers JD; Ho LP; Horsley A; Marks M; Poinasamy K; Raman B; Leavy OC; Richardson M; Elneima O; McAuley HJC; Shikotra A; Singapuri A; Sereno M; Saunders RM; Harris VC; Houchen-Wolloff L; Mansoori P; Greening NJ; Harrison EM; Docherty AB; Lone NI; Quint J; Greenhalf W; Wain LV; Brightling CE; Evans RE; Harrison PJ; Koychev I;
    Brain Commun; 2024; 6(1):fcad357. PubMed ID: 38229877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Central nervous system biomarkers GFAp and NfL associate with post-acute cognitive impairment and fatigue following critical COVID-19.
    Bark L; Larsson IM; Wallin E; Simrén J; Zetterberg H; Lipcsey M; Frithiof R; Rostami E; Hultström M
    Sci Rep; 2023 Aug; 13(1):13144. PubMed ID: 37573366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mid and long-term neurological and neuropsychiatric manifestations of post-COVID-19 syndrome: A meta-analysis.
    Premraj L; Kannapadi NV; Briggs J; Seal SM; Battaglini D; Fanning J; Suen J; Robba C; Fraser J; Cho SM
    J Neurol Sci; 2022 Mar; 434():120162. PubMed ID: 35121209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Absence of self-reported neuropsychiatric and somatic symptoms after Omicron variant SARS-CoV-2 breakthrough infections.
    Woo MS; Mayer C; Brehm TT; Andersen G; Weigel A; Löwe B; Lohse AW; Addo MM; Gerloff C; Knobloch JKM; Schulze Zur Wiesch J; Friese MA
    Brain Commun; 2023; 5(2):fcad092. PubMed ID: 37038497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma Biomarkers of Neuropathogenesis in Hospitalized Patients With COVID-19 and Those With Postacute Sequelae of SARS-CoV-2 Infection.
    Hanson BA; Visvabharathy L; Ali ST; Kang AK; Patel TR; Clark JR; Lim PH; Orban ZS; Hwang SS; Mattoon D; Batra A; Liotta EM; Koralnik IJ
    Neurol Neuroimmunol Neuroinflamm; 2022 May; 9(3):. PubMed ID: 35256481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transient Changes in the Plasma of Astrocytic and Neuronal Injury Biomarkers in COVID-19 Patients without Neurological Syndromes.
    Lennol MP; Ashton NJ; Moreno-Pérez O; García-Ayllón MS; Ramos-Rincon JM; Andrés M; León-Ramírez JM; Boix V; Gil J; Blennow K; Merino E; Zetterberg H; Sáez-Valero J
    Int J Mol Sci; 2023 Feb; 24(3):. PubMed ID: 36769057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuropsychiatric and Cognitive Outcomes in Patients 6 Months After COVID-19 Requiring Hospitalization Compared With Matched Control Patients Hospitalized for Non-COVID-19 Illness.
    Nersesjan V; Fonsmark L; Christensen RHB; Amiri M; Merie C; Lebech AM; Katzenstein T; Bang LE; Kjærgaard J; Kondziella D; Benros ME
    JAMA Psychiatry; 2022 May; 79(5):486-497. PubMed ID: 35319743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum Tau, Neurofilament Light Chain, Glial Fibrillary Acidic Protein, and Ubiquitin Carboxyl-Terminal Hydrolase L1 Are Associated with the Chronic Deterioration of Neurobehavioral Symptoms after Traumatic Brain Injury.
    Lange RT; Lippa S; Brickell TA; Gill J; French LM
    J Neurotrauma; 2023 Mar; 40(5-6):482-492. PubMed ID: 36170576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuropsychiatric Ramifications of Severe COVID-19 and Other Severe Acute Respiratory Infections.
    Clift AK; Ranger TA; Patone M; Coupland CAC; Hatch R; Thomas K; Hippisley-Cox J; Watkinson P
    JAMA Psychiatry; 2022 Jul; 79(7):690-698. PubMed ID: 35544272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perceived Cognitive Deficits in Patients With Symptomatic SARS-CoV-2 and Their Association With Post-COVID-19 Condition.
    Liu TC; Yoo SM; Sim MS; Motwani Y; Viswanathan N; Wenger NS
    JAMA Netw Open; 2023 May; 6(5):e2311974. PubMed ID: 37145596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New‑onset neuropsychiatric sequelae and 'long‑COVID' syndrome (Review).
    Efstathiou V; Stefanou MI; Demetriou M; Siafakas N; Katsantoni E; Makris M; Tsivgoulis G; Zoumpourlis V; Kympouropoulos SP; Tsoporis JN; Spandidos DA; Ferentinos P; Smyrnis N; Rizos E
    Exp Ther Med; 2022 Nov; 24(5):705. PubMed ID: 36324612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma glial fibrillary acidic protein and neurofilament light chain, but not tau, are biomarkers of sports-related mild traumatic brain injury.
    Laverse E; Guo T; Zimmerman K; Foiani MS; Velani B; Morrow P; Adejuwon A; Bamford R; Underwood N; George J; Brooke D; O'Brien K; Cross MJ; Kemp SPT; Heslegrave AJ; Hardy J; Sharp DJ; Zetterberg H; Morris HR
    Brain Commun; 2020; 2(2):fcaa137. PubMed ID: 33543129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurological involvement among non-hospitalized adolescents and young adults 6 months after acute COVID-19.
    Havdal LB; Selvakumar J; Lund Berven L; Stiansen-Sonerud T; Zetterberg H; Blennow K; Holmøy T; Wyller VBB
    Front Neurol; 2024; 15():1345787. PubMed ID: 38385031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Longitudinal analysis and treatment of neuropsychiatric symptoms in post-acute sequelae of COVID-19.
    Liu EN; Yang JH; Patel L; Arora J; Gooding A; Ellis R; Graves JS
    J Neurol; 2023 Oct; 270(10):4661-4672. PubMed ID: 37493802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Health outcomes in people 2 years after surviving hospitalisation with COVID-19: a longitudinal cohort study.
    Huang L; Li X; Gu X; Zhang H; Ren L; Guo L; Liu M; Wang Y; Cui D; Wang Y; Zhang X; Shang L; Zhong J; Wang X; Wang J; Cao B
    Lancet Respir Med; 2022 Sep; 10(9):863-876. PubMed ID: 35568052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biomarkers for central nervous system injury in cerebrospinal fluid are elevated in COVID-19 and associated with neurological symptoms and disease severity.
    Virhammar J; Nääs A; Fällmar D; Cunningham JL; Klang A; Ashton NJ; Jackmann S; Westman G; Frithiof R; Blennow K; Zetterberg H; Kumlien E; Rostami E
    Eur J Neurol; 2021 Oct; 28(10):3324-3331. PubMed ID: 33369818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurochemical signs of astrocytic and neuronal injury in acute COVID-19 normalizes during long-term follow-up.
    Kanberg N; Simrén J; Edén A; Andersson LM; Nilsson S; Ashton NJ; Sundvall PD; Nellgård B; Blennow K; Zetterberg H; Gisslén M
    EBioMedicine; 2021 Aug; 70():103512. PubMed ID: 34333238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blood biomarkers of neuronal injury in paediatric cerebral malaria and severe malarial anaemia.
    Datta D; Gopinadhan A; Soto A; Bangirana P; Opoka RO; Conroy AL; Saykin AJ; Kawata K; John CC
    Brain Commun; 2023; 5(6):fcad323. PubMed ID: 38075948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long COVID and neuropsychiatric manifestations (Review).
    Efstathiou V; Stefanou MI; Demetriou M; Siafakas N; Makris M; Tsivgoulis G; Zoumpourlis V; Kympouropoulos SP; Tsoporis JN; Spandidos DA; Smyrnis N; Rizos E
    Exp Ther Med; 2022 May; 23(5):363. PubMed ID: 35493431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fatigue and cognitive impairment after COVID-19: A prospective multicentre study.
    Hartung TJ; Neumann C; Bahmer T; Chaplinskaya-Sobol I; Endres M; Geritz J; Haeusler KG; Heuschmann PU; Hildesheim H; Hinz A; Hopff S; Horn A; Krawczak M; Krist L; Kudelka J; Lieb W; Maetzler C; Mehnert-Theuerkauf A; Montellano FA; Morbach C; Schmidt S; Schreiber S; Steigerwald F; Störk S; Maetzler W; Finke C
    EClinicalMedicine; 2022 Nov; 53():101651. PubMed ID: 36133318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.